Circular RNA HECTD1 knockdown inhibits transforming growth factor-beta/ small mothers against decapentaplegic (TGF-β/Smad) signaling to reduce hypertrophic scar fibrosis
Author:
Affiliation:
1. Department of Plastic and Burn Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China
Funder
funding agencies in the public, commercial, or not-for-profit
Publisher
Informa UK Limited
Subject
Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Link
https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2048771
Reference52 articles.
1. Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective
2. Novel Methods for the Investigation of Human Hypertrophic Scarring and Other Dermal Fibrosis
3. MiR-564 promotes hypertrophic scar formation through TGF-β1 upregulation
4. Inhibitory Effect of Delphinidin on Extracellular Matrix Production via the MAPK/NF-κB Pathway in Nasal Polyp-Derived Fibroblasts
5. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The emerging roles of circHECTD1 in human diseases and the specific underlying regulatory mechanisms;PeerJ;2024-06-24
2. The Pathophysiology and Management of Pathologic Scarring—a Contemporary Review;Advances in Wound Care;2024-04-25
3. Non-coding RNAs in hypertrophic scars and keloids: Current research and clinical relevance: A review;International Journal of Biological Macromolecules;2024-01
4. A comparative study of the efficacy and safety of pure silica gel and chitosan quaternary ammonium salt silica gel in hypertrophic scar treatment;Tropical Journal of Pharmaceutical Research;2023-09-15
5. Noncoding RNAs: Master Regulator of Fibroblast to Myofibroblast Transition in Fibrosis;International Journal of Molecular Sciences;2023-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3